Archiwum hase³
Shirmer`s test | yellowness | biologics | AMP-activated protein kinase {AMPK} | Akt kinase | transducer | phosphoinositide 3-kinase pathway {PI3K} | Akt isoforms | molecular toxicology | toxicity biomarkers | toxicology | environmental carcinogens | xenobiotic-metabolizing enzymes {XMEs} | epoxide hydrolase | epoxide hydratase | N-acetyltransferase | sulfotransferase | transcriptome | exposure biomarkers | blepharochalasis | lupus nephritis | nuclear localization signal {NLS} | taxanes | ventral tegmental area {VTA} | viability | glutamatergic transmission | HEK 293 | HEK cells | merozoite | neonatal severe primary hyperparathyroidism | nuclear localization sequence {NLS} | organic anion transporter {Oatp} | serine/ threonine protein kinase Akt | telomerase | tissue polypeptide antigen {TPA} | Prinzmetal angina | eplerenone | malonyl dialdehyde | adverse risk group | favorable risk group | cytogenetic | cytogenetics | lysosomotropic agents | lysosomotropic compounds | vacuoles | conjugated linoleic acid {CLA} | monocyte chemoattractant protein - 1 | nutraceuticals | functional food | medicinal food | polyphenols | cosmeceuticals | Barrett`s oesophagus | erythematotelangiectatic | papulopustular | phymatous | chronic allograft nephropathy {CAN} | effective renal plasma flow {ERPF} | interstitial fibrosis and tubular atrophy {IF/ TA} | non-insulin-dependent diabetes mellitus {NIDDM} | Diabetes mellitus type 2 | post-transplant anemia {PTA} | post-transplant erythrocytosis {PTE} | renal blood flow {RBF} | short tandem repeat polymorphism {STRP} | variable number of tandem repeats {VNTR} | scour | calf scours | moschus | connective tissue mast cells {CMC} | leukocyte adhesion molecule 1 | GATA binding protein {GATA3} | interferon inducible protein | mucosal mast cells {MMC} | cytotoxic lymphocytes | immune surveillance cells | stromal tumor mast cell | photodynamic therapy {PDT} | growth arrest and DNA damage inducible protein 45 {GADD45} | p53-regulated apoptosis-inducing protein 1 {p53AIP1} | wild type p53 {wtp53} | aberrant proliferative signals | oncogene activation | proteasomal degradation | p53 tumor suppressor protein | deep brachial artery | squamous cell carcinoma antigen {SCCA} {SSC-Ag} {SSC} | growth-related oncogene {GRO} | indoleamine 2,3-dioxygenase {IDO} | neutrophil activating protein {NAP} | antigen presenting cells {APC} | transforming growth factor {TGF} | primary hepatotropic viruses | macrophage {Mf} | transferrin receptor {sTfR} | tenodesis | scleroplasty | throbbing | lontophoresis | proliferation-inducing ligand {April} | B cell activating factor {BAFF} | B-cell receptor {BCR} | B lymphocyte stimulator {Blys} | CC chemokine ligand {CCL} | complete Freund\'s adjuvant {CFA} | collagen induced arthritis {CIA} | collagen II {COLL II} | cytotoxic T-lymphocyte-associated antigen-4 {CTLA4} | CXC chemokine ligand {CXCL} | extracellular signal regulated kinase | Fas ligand {FasL} {CD95L} | fragment crystallizable {Fc} | Fc receptor {FcR} | gut-associated lymphoid tissue {GALT} | incomplete Freund\'s adjuvant {IFA} | I kappa B kinase {IKK} | Janus tyrosine kinase {JAK}; {Jak} | c Jun N-terminal kinase {JNK} | tumor necrosis factor-beta | mitogen-activated protein kinase kinase {MAPKK} | natural killer T cell {NKT} | egg albumin | peptidylarginine deiminase 4 {PAD4} | spleen tyrosine kinase {Syk} | type 1 regulatory T cell {Tr1 cell} | TNF receptor-associated factor 1 {TRAF1} | ovalbumin {OVA} | pulmonary oedema | tumor lysis | pulmonary interstitial infiltrations | aliquot | sialidase | non-specific immunologic response | coiled bodies (CB) | automodification domain {AD} | apoptosis inducing factor {AIF} | ADP-ribose hydrolase 3 {ARH3} | base excision repair {BER} | DNA-dependent protein kinase {DNA-PK} | double-strand break {DSB} | double-strand end {DSE} | homologous recombination {HR} | high mobility protein group {HMG} | heterogeneous nuclear protein {hnRNP} | nicotinamide dinucleotide {NAD+ | nucleotide excision repair {NER} | nuclear factor κB {NF-κB} | single-strand break {SSB} | small ubiquitin-like modifier {SUMO} | domain structure | ribosylation | sumoylation | genome stability | catalytic domain {CD} | catenin | posttranslational modifications | adrenolytic | trabecula | trabeculation | dysesthesia | point estimation | hazard ratio | joint space | electrovaporization | indication | lipofuscin | lipofuscin granule | lutein | retinal antooxidative defense systems | photoreceptor outer segments {POS} | cytotoxic chain reaction | photoreceptor | retinal pigment epithelium {RPE } | photoinducible properties | xanthophylls | regenerative medicine | dissipation | lateral release | scar tissue | Ringer`s lactate | debulking | full fat | regulatory proteins | ubiquitin – proteasome system | UPS route | ubiquitination | ubiquitination process | biosurfactants | amphiphilic compounds | gelsolin | cytoplasmic gelsolin | plasma gelsolin | nailfold | juvenile idiopathic arthritis {JIA} | video capillaroscopy | videocapillaroscopy | peripheral microvessels | appetite control | agouti related peptide {AgRP} | agouti-related protein |
Poprzednia 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 Nastêpna
